BGR GOVERNMENT AFFAIRS for EISAI INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 22, 2018 | $20,000 | Replaced |
| 4th Quarter - Termination | Apr 20, 2018 | $20,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Medicare Part D; DEA scheduling of FDA approved products
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER | See prior filing |
| BRENT ALAN DEL MONTE | See prior filing |
| RYAN LONG | See prior filing |
| JENNIFER LARKIN LUKAWSKI | See prior filing |
| ROBB WALTON New | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi |
| ROBERT WOOD | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.